This study demonstrates that Cav-1 is a relevant regulator of aortic endothelial autophagy and suggests that pharmacological inhibition of Cav-1-activated autophagy may provide a potential therapeutic strategy for cardiovascular diseases including atherosclerosis. This evidence concerns the gene CAV1 and atherosclerosis.